参考文献

1.NOLLET J A.Recherches sur les causes particulieres des phénoménes électriques.Paris:Chez H.L.Guerin &L.F，Delatour，1754.

2.REILLY J P.Applied Bioelectricity:From Electrical Stimulation to Electropathology.New York:Springer，1998.

3.PRAUSNITZ M R.A practical assessment of transdermal drug delivery by skin electroporation.Advanced Drug Delivery Reviews，1999，35（1）:61-76.

4.VANBEVER R，PRÉAT V.In vivo efficacy and safety of skin electroporation.Advanced Drug Delivery Reviews，1999，35（1）:77-88.

5.NOAD H M.Lectures on electricity； comprosing galvnism，magnetism，electro-magnetism，magneto-and thermo-electricity and electo-physiology.3rd ed.London:George Knight and Sons，1849.

6.FULLER G W.Report on the investigations into the purification of the Ohio river water at Louisville Kentucky.New York:D.Van Nostrand Company，1898.

7.ROCKWELL A D.The Medical and surgical uses of electricity:including the X-ray，Finsen light，vibratory therapeutics，and high-frequency currents.New York:E.B.Treat & Company，1903.

8.JEX-BLAKE A J.The goulstonian lectures on death by electric currents and by lightning:Delivered before the Royal College of Physicians of London.British Medical Journal，1913，1（2723）:492-498.

9.MCKINLEY G M.“Short electric wave radiation in biology”in biological effects of radiation，vol.1，B.M.Duggar，Ed.New York:McGraw-Hill Book Co，1936.

10.HODGKIN A L.The ionic basis of electrical activity in nerve and muscle.Biological reviews of the Cambridge Philosophical Society，1951.

11.FRICKE H.A mathematical treatment of the electric conductivity and capacity of disperse systems Ⅱ.The capacity of a suspension of conducting spheroids surrounded by a non-conducting membrane for a current of low frequency.Physical Review，1925.

12.FRANKENHAEUSER B，WIDÉN L.Anode break excitation in desheathed frog nerve.J Physiol，1956，131（1）:243-247.

13.ZIMMERMANN U，PILWAT G，RIEMANN F.Dielectric Breakdown of Cell Membranes.Biophys J，1974，14（11）:881-899.

14.KINOSITA K J，TSONG T Y.Formation and resealing of pores of controlled sizes in human erythrocyte membrane.Nature，1977，268（5619）:438-441.

15.BELOV S V.Effects of high-frequency current parameters on tissue coagulation.Med Tekh，1978，12（4）:209-211.

16.ZIMMERMANN U.Electric field-mediated fusion and related electrical phenomena.Biochim Biophys Acta，1982，694（3）:227-277.

17.RAMOS C，TEISSIE J.Electrofusion:a biophysical modification of cell membrane and a mechanism in exocytosis.Biochimie，2000，82（5）:511-518.

18.NEUMANN E，SCHAEFFER-RIDDER M，WANG Y，et al.Gene transfer into mouse lymphoma cells by electroporation in high electric fields.EMBO J，1982，1（7）:841-845.

19.OKINO M，MOHRI H.Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors.Jpn J Cancer Res，1987，78（12）:1319-1321.

20.ORLOWSKIM S，BELEHRADEK J J，PAOLETTI C，et al.Transient electropermeabilization of cells in culture.Increase of the cytotoxicity of anticancer drugs.Biochem Pharmacol，1988，37（24）:4727-4733.

21.POWELL K T，MORGENTHALER A W，WEAVER J C.Tissue electroporation.Observation of reversible electrical breakdown in viable frog skin.Biophys J，1989，56（6）:1163-1171.

22.PRAUSNITZ M R，BOSE V G，LANGER R，et al.Electroporation of mammalian skin:a mechanism to enhance transdermal drug delivery.Proceedings of the National Academy of Sciences of the United States of America，1993，90（22）:10504-10508.

23.LEE RC，KOLODNEY M S.Electrical Injury Mechanisms:Electrical Breakdown of Cell Membranes.Plast Reconstr Surg，1987，80（5）:672-679.

24.NEUMANN E，SOWERS A E，JORDAN C A.Electroporation and Electrofusion in Cell Biology.New York:Plenum Press，1989.

25.POTTER H，WEIR L，LEDER P.Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.Proceedings of the National Academy of Sciences of the United States of America，1984，81（22）:7161-7165.

26.NICKOLOFF J A.Electroporation Protocols for Microorganisms.Totowa，New Jersey:Humana Press，1995.

27.TITOMIROV A V，SUKHAREV S，KISTANOVA E.In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA.Biochim Biophys Acta，1991，1088（1）:131-134.

28.MIR L M，MOLLER P H，ANDRÉ F，et al.Electric Pulse-Mediated Gene Delivery to Various Animal Tissues.Advances in Genetics，2005，54（1）:83-114.

29.LEE R C，RIVER L P，PAN F S，et al.Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo.Proceedings of the National Academy of Sciences of the United States of America，1992，89（10）:4524-4528.

30.PIÑERO J，LOPEZ-BAENA M，ORTIZ T，et al.Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells.Apoptosis，1997，2（3）:330-336.

31.GEHL J，SKOVSGAARD T，MIR L M.Vascular reactions to in vivo electroporation:characterization and consequences for drug and gene delivery.Biochim Biophys Acta，2002，1569（1/2/3）:51-58.

32.SCHOENBACH K H，PETERKIN F E，ALDEN R W，et al.The effect of pulsed electric fields on biological cells:experiments and applications.IEEE Trans.Plasma Science，1997，25:284-292.

33.YAO C，SUN C，MI Y，et al.Experimental studies on Killing and inhibiting effects of steep pulsed electric field（SPEF）to target cancer cell and solid tumor.IEEE Trans.Plasma Science，2004，32（4）:1626-1633.

34.DAVALOS R V，MIR L M，RUBINSKY B.Tissue Ablation with Irreversible Electroporation.Ann Biomed Eng，2005，33（2）:223-231.

35.MILLER L，LEOR J，RUBINSKY B.Cancer cells ablation with irreversible electroporation.Technol Cancer Res Treat，2005，4（6）:699-705.

36.EDD J，HOROWITZ L，DAVALOS R V，et al.In-Vivo Results of a New Focal Tissue Ablation Technique:Irreversible Electroporation.IEEE Trans.Biomed.Eng，2006，53（7）:1409-1415.

37.RUBINSKY B，ONIK G，MIKUS P.Irreversible electroporation:a new ablation modality-clinical implications.Technol Cancer Res Treat，2007，6（1）:37-48.

38.EDD J F，DAVALOS R V.Mathematical modeling of irreversible electroporation for treatment planning.Technol Cancer Res Treat，2007，6（4）:275-286.

39.MAOR E，IVORRA A，LEOR J，et al.The effect of irreversible electroporation on blood vessels.Technol Cancer Res Treat，2007，6（4）:307-312.

40.MAOR E，IVORRA A，LEOR J，et al.Irreversible electroporation attenuates neointimal formation after angioplasty.IEEE Trans.Biomed.Eng，2008，55（9）:2268-2274.

41.ONIK G，RUBINSKY B，MIKUS P.Irreversible Electroporation:Implications for Prostate Ablation.Technol Cancer Res Treat，2007，6（4）:295-300.

42.RUBINSKY J，ONIK G，MIKUS P，et al.Optimal Parameters for the Destruction of Prostate Cancer Using Irreversible Electroporation.J Urol，2008，180（6）:2668-2674.

43.AL-SAKERE B，BERNAT C，ANDRE F，et al.A study of the immunological response to tumor ablation with irreversible electroporation.Technol Cancer Res Treat，2007，6（4）:301-306.

44.AL-SAKERE B，ANDRÉF，BERNAT C，et al.Tumor ablation with irreversible electroporation.PLoS ONE，2007，2（11）:e1135.

45.MIKLAVCIC D，BERAVS K，SEMROV D，et al.The Importance of Electric Field Distribution for Effective in Vivo Electroporation of Tissues.Biophys J，1998，74（5）:2152-2158.

46.LAVEE J，ONIK G，MIKUS P，et al.A Novel Nonthermal Energy Source for Surgical Epicardial Atrial Ablation:Irreversible Electroporation.Heart Surg Forum，2007，10（2）:162-167.

47.TEKLE E，WOLFE M D，OUBRAHIM H，et al.Phagocytic clearance of electric field induced apoptosis-mimetic cells.Biochem Biophys Res Commun，2008，376（2）:256-260.

48.BALL C，THOMSON K R，KAVNOUDIAS H.Irreversible electroporation:A new challenge in“out of operating theater”anesthesia.Anesth Analg，2010，110（5）:1305-1309.

49.PECH M，JANITZKY A，WENDLER J J，et al.Irreversible electroporation of renal cell carcinoma:A first-in-man phase I clinical study.Cardiovasc Intervent Radiol，2011，34（1）:132-138.

50.THOMSON K R，CHEUNG W，ELLIS S J，et al.Investigation of the safety of irreversible electroporation in humans.J Vasc Interv Radiol，2011，22（5）:611-621.

51.KINGHAM T P，KARKAR A M，D'ANGELICA M I，et al.Ablation of perivascular hepatic malignant tumors with irreversible electroporation.J Am Coll Surg，2012，215（3）:379-387.

52.CHARPENTIER K P.Irreversible electroporation for the ablation of liver tumors:Are we there yet？Archives of Surgery，2012，147（11）:1053-1061.

53.MARTIN R C，MCFARLAND K，ELLIS S，et al.Irreversible electroporation in locally advanced pancreatic cancer:Potential improved overall survival.Ann Surg Oncol，2013，20（Suppl 3）:S443-S449.

54.CANNON R，ELLIS S，HAYES D，et al.Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures.J Surg Oncol，2013，107（5）:544-549.

55.ROSSMEISL J H，GARCIA P A，ROBERSTON J L，et al.Pathology of non-thermal irreversible electroporation（N-TIRE）-induced ablation of the canine brain.Journal of Veterinary Science，2013，14（4）:433-440.

56.SRIMATHVEERAVALLI G，WIMMER T，MONETTE S，et al.Evaluation of an endorectal electrode for performing focused irreversible electroporation ablations in the swine rectum.J Vasc Interv Radiol，2013，24（8）:1249-1256.

57.LEE Y J，LU D S，OSUAGWU F，et al.Irreversible electroporation in porcine liver:acute computed tomography appearance of ablation zone with histopathologic correlation.J Comput Assist Tomogr，2013，37（2）:154-158.

58.BEN-DAVID E，AHMED M，FAROJA M，et al.Irreversible electroporation:treatment effect is susceptible to local environment and tissue properties.Radiology，2013，269（3）:738-747.

59.MOIR J，WHITE S A，FRENCH J J，et al.Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer.Eur J Surg Oncol，2014，40（12）:1598-1604.

60.NARAYANAN G，BHATIA S，ECHENIQUE A，et al.Vessel patency post irreversible electroporation.Cardiovasc Intervent Radiol，2014，37（6）:1523-1529.

61.MARTIN R C，PHILIPS P，ELLIS S，et al.Irreversible electroporation of unresectable soft tissue tumors with vascular invasion:effective palliation.BMC Cancer，2014，14（1）:540.

62.VALERIO M，STRICKER P D，AHMED H U，et al.Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.Prostate Cancer Prostatic Dis，2014，17（4）:343-347.

63.NIELSEN K，SCHEFFER H J，VIEVEEN J M，et al.Anaesthetic management during open and percutaneous irreversible electroporation.Br J Anaesth，2014，113（6）:985-992.

64.DUNKI-JACOBS E M，PHILIPS P，MARTIN R C.Evaluation of thermal injury to liver，pancreas and kidney during irreversible electroporation in an in vivo experimental model.Br J Surg，2014，101（9）:1113-1121.

65.CHOI J W，LU D S，OSUAGWU F，et al.Assessment of chronological effects of irreversible electroporation on hilar bile ducts in a porcine model.Cardiovasc Intervent Radiol，2014，37（1）:224-230.

66.FROUD T，VENKAT S R，BARBERY K J，et al.Liver Function Tests Following Irreversible Electroporation of Liver Tumors:Experience in 174 Procedures.Tech Vasc Interv Radiol，2015，18（3）:140-146.

67.DOLLINGER M，BEYER L P，HAIMERL M，et al.Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance:a single-center experience.Diagn Interv Radiol，2015，21（6）:471-475.

68.DOLLINGER M，MÜLLER-WILLE R，ZEMAN F，et al.Irreversible Electroporation of Malignant Hepatic Tumors-Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.PLoS One，2015，10（8）:e0135773.

69.GOLBERG A，BRUINSMA B G，UYGUN B E，et al.Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by“electric field sinks”.Sci Rep，2015，（5）:8485.

70.RICKE J，JÜRGENS J H，DESCHAMPS F，et al.Irreversible electroporation（IRE）fails to demonstrate efficacy in a prospective multicenter phase Ⅱ trial on lung malignancies:the ALICE trial.Cardiovascular & Intervention Radiology，2015，38（2）:401-408.

71.SONG Y，ZHENG J，YAN M，et al.The Effect of Irreversible Electroporation on the Femur:Experimental Study in a Rabbit Model.Sci Rep，2015（5）:181-187.

72.ROSSMEISL J H，GARCIA P A，PANCOTTO T E，et al.Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.J Neurosurg，2015，123（4）:1008-1025.

73.SONG Y，ZHENG J，YAN M，et al.The Effects of Irreversible Electroporation on the Achilles Tendon:An Experimental Study in a Rabbit Model.PLoS One，2015，10（6）:e0131404.

74.WONG S S，HUI J W，CHAN A W，et al.Irreversible Electroporation of the Femoral Neurovascular Bundle:Imaging and Histologic Evaluation in a Swine Model.J Vasc Interv Radiol，2015，26（8）:1212-1220.

75.SRIMATHVEERAVALLI G，SILK M，WIMMER T，et al.Feasibility of catheter-directed intraluminal irreversible electroporation of porcine ureter and acute outcomes in response to increasing energy delivery.J Vasc Interv Radiol，2015，26（7）:1059-1066.

76.WAGSTAFF P G，DE BRUIN D M，VAN DEN BOS W，et al.Irreversible electroporation of the porcine kidney:Temperature development and distribution.Urol Oncol，2015，33（4）:168.e1-7.

77.VAN DEN BOS W，DE BRUIN D M，JURHILL R R，et al.The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.World J Urol，2016，34（5）:657-664.

78.SCHEFFER H J，VROOMEN L G，DE JONG M C，et al.Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation:Results of the Phase Ⅰ/Ⅱ PANFIRE Study.Radiology，2016，6:152835.

79.NIESSEN C，BEYER L P，PREGLER B，et al.Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation:A Prospective Safety and Midterm Efficacy Study in 34 Patients.J Vasc Interv Radiol，2016，27（4）:480-486.

80.KAMBAKAMBA P，BONVINI J M，GLENCK M，et al.Intraoperative adverse events during irreversible electroporation-A call for caution.American Journal of Surgery，2016，212（4）:715-721.

81.BEYER L P，PREGLER B，MICHALIK K，et al.Evaluation of a robotic system for irreversible electroporation（IRE）of malignant liver tumors:initial results.Int J Comput Assist Radiol Surg，2017，12（5）:803-809.

82.BEYER L P，PREGLER B，NIEEN C，et al.Stereotactically-navigated percutaneous Irreversible Electroporation（IRE）compared to conventional IRE:a prospective trial.PeerJ，2016（4）:e2277.

83.SANO M B，FAN R E，HWANG G L，et al.Production of Spherical Ablations Using Nonthermal Irreversible Electroporation:A Laboratory Investigation Using a Single Electrode and Grounding Pad.J Vasc Interv Radiol，2016，27（9）:1432-1440.

84.WANDEL A，BEN-DAVID E，ULUSOY B S，et al.Optimizing Irreversible Electroporation Ablation with a Bipolar Electrode.J Vasc Interv Radiol，2016，27（9）:1441-1450.

85.LI S，CHEN F，SHEN L，et al.Percutaneous irreversible electroporation for breast tissue and breast cancer:safety，feasibility，skin effects and radiologic-pathologic correlation in an animal study.J Transl Med，2016，14（1）:238.

86.TAM A L，FIGUEIRA T A，GAGEA M，et al.Irreversible Electroporation in the Epidural Space of the Porcine Spine:Effects on Adjacent Structures.Radiology，2016，281（3）:763-771.

87.SHARABI S，KOS B，LAST D，et al.A statistical model describing combined irreversible electroporation and electroporation-induced blood-brain barrier disruption.Radiol Oncol，2016，50（1）:28-38.

88.SCHEFFER H J，VOGEL J A，VAN DEN BOS W，et al.The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation.PLoS One，2016，11（2）:e0148457.

89.VAN DEN BOS W，SCHEFFER H J，VOGEL J A，et al.Thermal Energy during Irreversible Electroporation and the Influence of Different Ablation Parameters.J Vasc Interv Radiol，2016，27（3）:433-443.

90.姚陈果，孙才新，熊兰，等.电穿孔疗法用于肿瘤治疗的研究进展.生物医学工程学杂志，2002，19（2）:337-339.

91.姚陈果，孙才新，米彦，等.陡脉冲对恶性肿瘤细胞不可逆性电击穿的实验研究.中国生物医学工程学报，2004，23（1）:92-97.

92.杨孝军，李均，胡丽娜.电穿孔技术的研究及应用进展.中国康复医学杂志，2005，20（3）:239-240.

93.王士彬，孙才新，姚陈果，等.电穿孔技术的研究及应用进展.国外医学.生物医学工程分册，2005，28（6）:370-373.

94.李均，杨孝军，胡丽娜，等.陡脉冲电场对兔 VX2 乳腺移植瘤毛细淋巴管的影响.癌症:英文版，2006，25（2）:159-162.

95.杨晓燕，熊正爱.陡脉冲不可逆性电击穿的作用机制及其在肿瘤治疗中的应用.国际肿瘤学杂志，2008，35（8）:594-596.

96.张琴.脉冲电场不可逆性电击穿在肿瘤治疗中的研究进展.重庆医学，2011，40（3）:298-300.

97.何晓锋，肖越勇.纳米刀肿瘤消融治疗的临床应用进展.中华放射学杂志，2014，48（10）:878-880.

98.杜鹏，肖越勇，张欣，等.采用CT灌注成像评价猪肾脏经皮纳米刀消融后急性期血流灌注的变化.中华放射学杂志，2014，48（11）:952-955.

99.肖越勇，张欣.纳米刀消融技术在肝癌中的应用.肝癌电子杂志，2015，2（2）:23-24.

100.宋飞虹，陈永亮，苏明，等.纳米刀消融胰腺组织的动物实验.中华肝胆外科杂志，2015，21（5）:328-331.

101.严力，陈永亮.不可逆性电穿孔在局部进展期胰腺癌治疗中的应用.中华肝胆外科杂志，2016，22（1）:68-70.

102.严力，陈永亮，苏明，等.纳米刀治疗局部进展期胰腺癌的效果及安全性评价.中华肝胆外科杂志，2016，22（4）:244-248.

103.牛立志，曾健滢，张志凯，等.纳米刀治疗胰腺癌现状.中华胰腺病杂志，2014，14（6）:420-423.

104.梁冰，牛立志，曾健滢，等.不可逆电穿孔消融兔胆囊侧肝脏病理学观察.介入放射学杂志，2014，23（4）:320-324.

105.曾健滢，牛立志，梁冰，等.兔胰腺不可逆电穿孔消融.中华胰腺病杂志，2015，15（2）:125-126.

106.牛立志，曾健滢，张怡湜，等.不可逆电穿孔消融治疗胰腺癌的安全性及近期疗效观察.介入放射学杂志，2016，25（3）:225-230.

107.牛立志，曾健滢，罗小美，等.胃癌术后复发性病变的不可逆电穿孔消融 1 例.介入放射学杂志，2016，25（1）:50-51.

108.牛立志，刘桂凤，曾健滢，等.肝恶性肿瘤不可逆电穿孔消融的安全性和近期疗效.中华放射学杂志，2016，50（7）:526-530.

109.方刚，曾健滢，牛立志，等.不可逆电穿孔消融兔肾研究.中华实验外科杂志，2015，32（6）:1360.

110.黎升，曾奇，钟锐，等.不可逆电穿孔与射频消融后猪肝脏再生的比较.中华医学杂志，2015，95（1）:66-68.

111.宁周雨，王鹏，陈颢，等.不可逆电穿孔治疗胰腺癌的动物实验研究.中华胰腺病杂志，2015，15（6）:373-378.

112.余俊豪.肝癌的经皮不可逆电穿孔治疗.肝癌电子杂志，2015，2（1）:43-44.